Table 1.
Country | mg/L | |||
---|---|---|---|---|
Western Pacific (Japan) |
1–3 months 3–6 months |
1155 1
1155 1 |
1.8 ± 3.3 0.5 ± 1.4 |
Yamawaki et al. (2005) [17] |
Americas (Brazil) |
2 months | 31 | 0.9 ± 0.5 | Mastroeni et al. (2006) [18] |
South-East Asia (India) |
3.5 months | 100 3 | 0.3 | Shashiraj et al. (2006) [19] |
Americas (USA) |
1–1.5 months 2.5–3 months |
30 17 |
0.5 ± 1.0 0.4 ± 0.3 |
Hannan et al. (2008) [20] |
Eastern Mediterranean (Iran) | 3–4 months | 182 | 0.9 ± 0.5 | Mahdavi et al. (2009) [21] |
Western Pacific (Mongolia) |
1–6 months | 66 | 0.5 ± 0.2 | Shi et al. (2011) [22] |
Western Pacific (South Korea) |
3 months 4 months 5 months |
87 2
86 2 66 2 |
0.4 ± 0.3 0.4 ± 0.7 0.3 ± 0.2 |
Kim et al. (2017) [23] |
South-East Asia (Indonesia) |
2–5.3 months | 113 | 0.2 (0.2, 0.3) | Daniels et al. (2018) [16] |
1 Sample included an unknown number of infants born <2.5 kg and/or mothers using supplements (unknown number and type). 2 50% of the total sample took supplements (unknown type). 3 Included anemic and non-anemic women.